CDK6 and colorectal carcinoma: Konishi et al.23 reported that miR-26a suppressed the progression CRC through inhibition of the binding of Heterogeneous ribonucleoprotein A1 (hnRNP A1)—cyclin dependent kinase 6 (CDK6).